AzTrials
AzTrials

Comprehensive EducationNCT03638752

The Impact of Comprehensive Education Before Gastroscopy on Improving the Tolerance of Patients

A study testing Comprehensive education group in people with Comprehensive Education, run by Ningbo No. 1 Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This clinical trial is being conducted to assess whether the comprehensive education before gastroscopy could reduce the adverse reactions, such as nausea, vomiting and improve patient satisfaction. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Comprehensive Education
What is being tested?
Comprehensive education group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
260 participants
Where
1 siteChina
Study dates
15 Aug 2018to 15 Sep 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients over the age of 18 years undergoing routine gastroscopy
  • Informed consent

Who cannot join

  • Serious coronary heart disease and myocardial injury with serious heart failure
  • Stenosis of the esophagus or cardia obstruction
  • Acute pharyngitis and tonsillitis
  • Acute upper gastrointestinal bleeding
  • Hemodynamically unstable
  • allergy to topical lidocaine
  • Patients did not cooperate or spirit was not normal
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

China1 site
  • Ningbo NO.1 hospital

    Ningbo, Zhejiang, 315010

Other trials in China

About this study

Official title: The Impact of Comprehensive Education Before Gastroscopy on Improving the Tolerance of Patients: A Prospective Randomized Controlled Study

This clinical trial is being conducted to assess whether the comprehensive education before gastroscopy could reduce the adverse reactions, such as nausea, vomiting and improve patient satisfaction.

Being tested
Comprehensive education group

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Comprehensive education groupOther

    The details of Comprehensive education are as follows:

    1. introduce the purpose, method and function of breathing training and the whole process of gastroscopy;
    2. instruct patients to take deep breath training, inhaling with his/her nose and exhaling with his/her mouth,
    3. provide patients with a disposable dental biting device and repeat exercising deep breathing again until he/she is fully mastered,
    4. inform patients to cooperate with the instructions issued by endoscopist and endoscopy nurse during the whole process of gastroscopy,
    5. inform patients to inhale with nose and exhale with mouth when the gastroscope passes through the throat, then he/she should perform inhaling and exhaling with his/her nose until the end of the gastroscopy when the endoscopist ask to adjust the breathing method,
    6. inform patients that there would be some normal physiological reaction when gastroscopy, such as throat discomfort and nausea/vomiting.
Study groups in NCT03638752
Study groupRoleWhat they receive
Comprehensive education groupExperimentalThe details of Comprehensive education are as follows: 1. introduce the purpose, method and function of breathing training and the whole process of gastroscopy; 2. instruct patients to take deep breath training, inhaling with his/her nose and exhaling with his/her mouth, 3. provide patients with a disposable dental biting device and repeat exercising deep breathing again until he/she is fully mastered, 4. inform patients to cooperate with the instructions issued by endoscopist and endoscopy nurse during the whole process of gastroscopy, 5. inform patients to inhale with nose and exhale with mouth when the gastroscope passes through the throat, then he/she should perform inhaling and exhaling with his/her nose until the end of the gastroscopy when the endoscopist ask to adjust the breathing method, 6. inform patients that there would be some normal physiological reaction when gastroscopy, such as throat discomfort and nausea/vomiting.
Receives: Other: Comprehensive education group
standard educationNo interventionThe details of standard education are as follows: 1. inform patients to cooperate with the instructions issued by endoscopist and endoscopy nurse during the whole process of gastroscopy, 2. inform patients that there would be some normal physiological reaction when gastroscopy, such as the throat discomfort and nausea/vomiting.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adverse reaction times in gastroscopy

    research assistant records nausea/vomiting/retching times in the whole process of gastroscopy

    Measured: 1 day

Secondary outcomes (1)
  1. Patients' tolerance scores

    At the end of the procedure, the patients were asked about the tolerance in the process of gastroscopy by using a 100-mm visual analogue scale. Tolerance includes the extent of pain and nausea. The endpoints were assigned "no nausea or no pain " to the left and "worst possible nausea or worst pain imaginable " to the right.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2018
  2. Study start15 Aug 2018
  3. Primary completion15 Aug 2018
  4. Study completion15 Sep 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Care provider, Investigator
Enrolment
260 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03638752
Sponsor's protocol ID
2018-R010
Status last verified
Jun 2019
First submitted
8 Aug 2018
Last updated
2 Jul 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Comprehensive education group in people with Comprehensive Education, run by Ningbo No. 1 Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adverse reaction times in gastroscopy (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in